The role of metabolomics in neonatal and pediatric laboratory medicine

Michele Mussap, Roberto Antonucci, Antonio Noto, Vassilios Fanos

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Metabolomics consists of the quantitative analysis of a large number of low molecular mass metabolites involving substrates or products in metabolic pathways existing in all living systems. The analysis of the metabolic profile detectable in a human biological fluid allows to instantly identify changes in the composition of endogenous and exogenous metabolites caused by the interaction between specific physiopathological states, gene expression, and environment. In pediatrics and neonatology, metabolomics offers new encouraging perspectives for the improvement of critically ill patient outcome, for the early recognition of metabolic profiles associated with the development of diseases in the adult life, and for delivery of individualized medicine. In this view, nutrimetabolomics, based on the recognition of specific cluster of metabolites associated with nutrition and pharmacometabolomics, based on the capacity to personalize drug therapy by analyzing metabolic modifications due to therapeutic treatment may open new frontiers in the prevention and in the treatment of pediatric and neonatal diseases. This review summarizes the most relevant results published in the literature on the application of metabolomics in pediatric and neonatal clinical settings. However, there is the urgent need to standardize physiological and preanalytical variables, analytical methods, data processing, and result presentation, before establishing the definitive clinical value of results.

Original languageEnglish
Pages (from-to)127-138
Number of pages12
JournalClinica Chimica Acta
Volume426
DOIs
Publication statusPublished - Nov 15 2013

Fingerprint

Pediatrics
Metabolomics
Metabolites
Medicine
Metabolome
Infant, Newborn, Diseases
Neonatology
Drug therapy
Precision Medicine
Molecular mass
Nutrition
Metabolic Networks and Pathways
Chemical analysis
Critical Illness
Gene expression
Therapeutics
Gene Expression
Drug Therapy
Fluids
Substrates

Keywords

  • Mass spectrometry
  • Metabolomics
  • Nutrimetabolomics
  • Pharmametabolomics
  • Proton nuclear magnetic resonance spectroscopy
  • System biology

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The role of metabolomics in neonatal and pediatric laboratory medicine. / Mussap, Michele; Antonucci, Roberto; Noto, Antonio; Fanos, Vassilios.

In: Clinica Chimica Acta, Vol. 426, 15.11.2013, p. 127-138.

Research output: Contribution to journalArticle

Mussap, Michele ; Antonucci, Roberto ; Noto, Antonio ; Fanos, Vassilios. / The role of metabolomics in neonatal and pediatric laboratory medicine. In: Clinica Chimica Acta. 2013 ; Vol. 426. pp. 127-138.
@article{eeb84ee0fb1b4d0eb40bb4a1a93492f5,
title = "The role of metabolomics in neonatal and pediatric laboratory medicine",
abstract = "Metabolomics consists of the quantitative analysis of a large number of low molecular mass metabolites involving substrates or products in metabolic pathways existing in all living systems. The analysis of the metabolic profile detectable in a human biological fluid allows to instantly identify changes in the composition of endogenous and exogenous metabolites caused by the interaction between specific physiopathological states, gene expression, and environment. In pediatrics and neonatology, metabolomics offers new encouraging perspectives for the improvement of critically ill patient outcome, for the early recognition of metabolic profiles associated with the development of diseases in the adult life, and for delivery of individualized medicine. In this view, nutrimetabolomics, based on the recognition of specific cluster of metabolites associated with nutrition and pharmacometabolomics, based on the capacity to personalize drug therapy by analyzing metabolic modifications due to therapeutic treatment may open new frontiers in the prevention and in the treatment of pediatric and neonatal diseases. This review summarizes the most relevant results published in the literature on the application of metabolomics in pediatric and neonatal clinical settings. However, there is the urgent need to standardize physiological and preanalytical variables, analytical methods, data processing, and result presentation, before establishing the definitive clinical value of results.",
keywords = "Mass spectrometry, Metabolomics, Nutrimetabolomics, Pharmametabolomics, Proton nuclear magnetic resonance spectroscopy, System biology",
author = "Michele Mussap and Roberto Antonucci and Antonio Noto and Vassilios Fanos",
year = "2013",
month = "11",
day = "15",
doi = "10.1016/j.cca.2013.08.020",
language = "English",
volume = "426",
pages = "127--138",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - The role of metabolomics in neonatal and pediatric laboratory medicine

AU - Mussap, Michele

AU - Antonucci, Roberto

AU - Noto, Antonio

AU - Fanos, Vassilios

PY - 2013/11/15

Y1 - 2013/11/15

N2 - Metabolomics consists of the quantitative analysis of a large number of low molecular mass metabolites involving substrates or products in metabolic pathways existing in all living systems. The analysis of the metabolic profile detectable in a human biological fluid allows to instantly identify changes in the composition of endogenous and exogenous metabolites caused by the interaction between specific physiopathological states, gene expression, and environment. In pediatrics and neonatology, metabolomics offers new encouraging perspectives for the improvement of critically ill patient outcome, for the early recognition of metabolic profiles associated with the development of diseases in the adult life, and for delivery of individualized medicine. In this view, nutrimetabolomics, based on the recognition of specific cluster of metabolites associated with nutrition and pharmacometabolomics, based on the capacity to personalize drug therapy by analyzing metabolic modifications due to therapeutic treatment may open new frontiers in the prevention and in the treatment of pediatric and neonatal diseases. This review summarizes the most relevant results published in the literature on the application of metabolomics in pediatric and neonatal clinical settings. However, there is the urgent need to standardize physiological and preanalytical variables, analytical methods, data processing, and result presentation, before establishing the definitive clinical value of results.

AB - Metabolomics consists of the quantitative analysis of a large number of low molecular mass metabolites involving substrates or products in metabolic pathways existing in all living systems. The analysis of the metabolic profile detectable in a human biological fluid allows to instantly identify changes in the composition of endogenous and exogenous metabolites caused by the interaction between specific physiopathological states, gene expression, and environment. In pediatrics and neonatology, metabolomics offers new encouraging perspectives for the improvement of critically ill patient outcome, for the early recognition of metabolic profiles associated with the development of diseases in the adult life, and for delivery of individualized medicine. In this view, nutrimetabolomics, based on the recognition of specific cluster of metabolites associated with nutrition and pharmacometabolomics, based on the capacity to personalize drug therapy by analyzing metabolic modifications due to therapeutic treatment may open new frontiers in the prevention and in the treatment of pediatric and neonatal diseases. This review summarizes the most relevant results published in the literature on the application of metabolomics in pediatric and neonatal clinical settings. However, there is the urgent need to standardize physiological and preanalytical variables, analytical methods, data processing, and result presentation, before establishing the definitive clinical value of results.

KW - Mass spectrometry

KW - Metabolomics

KW - Nutrimetabolomics

KW - Pharmametabolomics

KW - Proton nuclear magnetic resonance spectroscopy

KW - System biology

UR - http://www.scopus.com/inward/record.url?scp=84884958498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884958498&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2013.08.020

DO - 10.1016/j.cca.2013.08.020

M3 - Article

C2 - 24035970

AN - SCOPUS:84884958498

VL - 426

SP - 127

EP - 138

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -